PATENT CLAIM ANALYSIS

Application Number: 15895333
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "451000"]

Abstract:
Described herein are pharmaceutical compositions providing enhanced bioavailability of polyunsaturated fatty acids and methods of manufacturing the same. In particular, described herein are pharmaceutical compositions comprising soft enteric capsules that provide enhanced bioavailability of omega-3 polyunsaturated fatty acids. The oral pharmaceutical compositions described herein are useful as nutritional supplements or for the treatment of cardiovascular-related diseases, such as hyper dyslipidemia and moderate to high triglyceride levels.

Claim (Index 86):
A method for treating or reducing symptoms of a cardiovascular-related disease comprising administering to a subject in need thereof an oral pharmaceutical composition comprising an enteric soft capsule shell comprising gelatin and an enteric polymer;\n wherein a weight ratio of the enteric polymer to gelatin is 1:2.6; and wherein the shell encapsulates a matrix fill comprising at least 94% by weight eicosapentaenoic free fatty acid (EPA) and less than 1% by weight docosahexaenoic acid (DHA).

Metadata:
- Claim Count in Document: 62.0
- Percentile: 88.0
- Lexical Diversity: 1.47917
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14749671', '14527201', '15895344', '15718531', '15404368']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7660296153363012
- 35 USC 102 Novelty (BERT): 0.6165260836262266
- Combined Prediction Score: 0.7510792621652937
- Mean Citation Score: 430.508002
- Max Citation Score: 587.3669
- Similarity Product: 510.88128000829215

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test